Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
Title: Assessing the Impact of Additional Serratus Anterior Block on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients Purpose: This randomized controlled trial aims to evaluate whether the addition of a Serratus Anterior Plane Block (SAPB) to the standard Rhomboid Intercostal Block (RIB) improves postoperative pain management in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS). Study Design:
- Type: Randomized Controlled Trial (RCT)
- Participants: 50 patients aged 18 -70 requiring VATS, randomized into two groups: one receiving RIB alone, and the other receiving RIB + SAPB.
- Duration: Pain and opioid consumption will be measured within 48 hours post-surgery.
- Outcome Measures: Pain levels using the Visual Analog Scale (VAS), opioid usage, and patient satisfaction. Significance: The study addresses the gap in research regarding the combined use of SAPB and RIB in pain control for VATS. It hypothesizes that the combination will lead to better pain relief and reduced opioid dependence compared to RIB alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2025
CompletedFirst Posted
Study publicly available on registry
February 20, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 28, 2025
January 1, 2025
1.2 years
January 20, 2025
August 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Severity
Postoperative pain will be assessed using the Visual Analog Scale for pain which higher score mean more pain at various time intervals (e.g., 1,12, 24, 36 and 48 hours post-surgery).
48 hours post-surgery.
Secondary Outcomes (1)
Opioid Consumption
48 hours post-surgery.
Study Arms (2)
Arm 1 (RIB Only)
EXPERIMENTALParticipants receive a Rhomboid Intercostal Block (RIB) as the sole regional anesthesia technique for postoperative pain management after VATS
Arm 2 (RIB + SAPB)
EXPERIMENTALParticipants receive both RIB and SAPB within 24 hours postoperatively
Interventions
A combination of two regional anesthesia techniques, Rhomboid Intercostal Block (RIB) and Serratus Anterior Plane Block (SAPB),(THE SAPB will received within 24 hours after RIB) administered under ultrasound guidance. SAPB targets the lateral cutaneous branches of the thoracic nerves, complementing the pain relief provided by RIB. This combination is used in Arm 2 to enhance postoperative analgesia.
Rhomboid Intercostal Block (RIB) A regional anesthesia technique administered under ultrasound guidance for postoperative pain relief. This will be used as the sole intervention in Arm 1.
Eligibility Criteria
You may qualify if:
- Adults aged 18-70 years.
- Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS).
- Classified as ASA physical status I-III (low to moderate surgical risk).
- Ability to provide informed consent and follow study protocols.
You may not qualify if:
- Known allergy or hypersensitivity to local anesthetics.
- Presence of bleeding disorders or anticoagulant use.
- History of chronic opioid use or opioid dependence.
- Anatomical abnormalities or conditions preventing the application of regional anesthesia (e.g., chest wall deformities).
- Presence of neurological disorders affecting pain perception.
- Cognitive impairments, language barriers, or inability to communicate effectively.
- Pregnancy or breastfeeding.
- Refusal or inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al Ahli hospital
Hebron, Palestinian Territories
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2025
First Posted
February 20, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 28, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share